Literature DB >> 17717014

Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.

Gwen Vanneste1, Ingeborg Dhaese, Patrick Sips, Emmanuel Buys, Peter Brouckaert, Romain A Lefebvre.   

Abstract

The principal target of the relaxant neurotransmitter nitric oxide (NO) is soluble guanylate cyclase (sGC). As the alpha(1)beta(1)-isoform of sGC is the predominant one in the gastrointestinal tract, the aim of this study was to investigate the role of sGC in nitrergic regulation of gastric motility in male and female sGCalpha(1) knock-out (KO) mice. In circular gastric fundus muscle strips, functional responses and cGMP levels were determined in response to nitrergic and non-nitrergic stimuli. sGC subunit mRNA expression in fundus was measured by real-time RT-PCR; in vivo gastric emptying of a phenol red meal was determined. No changes were observed in sGC subunit mRNA levels between wild-type (WT) and KO tissues. Nitrergic relaxations induced by short trains of electrical field stimulation (EFS) were abolished, while those by long trains of EFS were reduced in KO strips; the latter responses were abolished by 1H[1,2,4,]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). The relaxations evoked by exogenous NO and the NO-independent sGC activator BAY 41-2272 were reduced in KO strips but still sensitive to ODQ. Relaxations induced by vasoactive intestinal peptide (VIP) and 8-bromo-cGMP were not influenced. Basal cGMP levels were decreased in KO strips but NO, long train EFS and BAY 41-2272 still induced a moderate ODQ-sensitive increase in cGMP levels. Gastric emptying, measured at 15 and 60 min, was increased at 15 min in male KO mice. sGCalpha(1)beta(1) plays an important role in gastric nitrergic relaxation in vitro, but some degree of nitrergic relaxation can occur via sGCalpha(2)beta(1) activation in sGCalpha(1) KO mice, which contributes to the moderate in vivo consequence on gastric emptying.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717014      PMCID: PMC2277007          DOI: 10.1113/jphysiol.2007.140608

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  52 in total

1.  Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain.

Authors:  Evanthia Mergia; Michael Russwurm; Georg Zoidl; Doris Koesling
Journal:  Cell Signal       Date:  2003-02       Impact factor: 4.315

2.  Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.

Authors:  B Simon; H Kather
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

Review 3.  The physiology and pathophysiology of gastric emptying in humans.

Authors:  H Minami; R W McCallum
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

4.  Control of coronary vascular tone by nitric oxide.

Authors:  M Kelm; J Schrader
Journal:  Circ Res       Date:  1990-06       Impact factor: 17.367

5.  Influence of sildenafil on gastric sensorimotor function in humans.

Authors:  Giovanni Sarnelli; Daniel Sifrim; Jozef Janssens; Jan Tack
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-11       Impact factor: 4.052

6.  Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.

Authors:  Sofie Nimmegeers; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Johan Van de Voorde
Journal:  Cardiovasc Res       Date:  2007-06-12       Impact factor: 10.787

7.  Modulation of Ca2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice.

Authors:  Johan Bonnevier; Reinhard Fässler; Andrew P Somlyo; Avril V Somlyo; Anders Arner
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

8.  Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats.

Authors:  Mauro Cabral de Rosalmeida; Luciana Duarte Sobreira Saraiva; José Ronaldo Vasconcelos da Graça; Bruno Barreto Ivo; Marcel Vieira da Nóbrega; Francisco Assis Aquino Gondim; Francisco Hélio Rola; Armenio Aguiar dos Santos
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

9.  Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus.

Authors:  C G Li; M J Rand
Journal:  Eur J Pharmacol       Date:  1990-12-04       Impact factor: 4.432

Review 10.  Nitric oxide in gastrointestinal health and disease.

Authors:  Vijay Shah; Greg Lyford; Greg Gores; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  9 in total

1.  Modulation of gastric motility by brain-gut peptides using a novel non-invasive miniaturized pressure transducer method in anesthetized rodents.

Authors:  Guillaume Gourcerol; David W Adelson; Mulugeta Million; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2011-01-22       Impact factor: 3.750

Review 2.  Nitric oxide and its role as a non-adrenergic, non-cholinergic inhibitory neurotransmitter in the gastrointestinal tract.

Authors:  Kenton M Sanders; Sean M Ward
Journal:  Br J Pharmacol       Date:  2018-09-03       Impact factor: 8.739

Review 3.  RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Authors:  Iraida G Sharina; Gilbert J Cote; Emil Martin; Marie-Francoise Doursout; Ferid Murad
Journal:  Nitric Oxide       Date:  2011-08-16       Impact factor: 4.427

4.  Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

5.  Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.

Authors:  Ole De Backer; Ellen Elinck; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-18       Impact factor: 3.000

6.  Small intestinal motility in soluble guanylate cyclase alpha1 knockout mice: (Jejunal phenotyping of sGCalpha1 knockout mice).

Authors:  Ingeborg Dhaese; Gwen Vanneste; Patrick Sips; Emmanuel S Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-04       Impact factor: 3.000

7.  Heme deficiency of soluble guanylate cyclase induces gastroparesis.

Authors:  S M R Cosyns; I Dhaese; R Thoonen; E S Buys; A Vral; P Brouckaert; R A Lefebvre
Journal:  Neurogastroenterol Motil       Date:  2013-03-28       Impact factor: 3.598

8.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

Review 9.  Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.

Authors:  Emmanuel S Buys; Lincoln R Potter; Louis R Pasquale; Bruce R Ksander
Journal:  Front Mol Neurosci       Date:  2014-05-19       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.